Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 696 Neoplasms 618 Prostatic Neoplasms 317 Lung Neoplasms 312 Colorectal Neoplasms 281 Carcinoma, Non-Small-Cell Lung 254 Pancreatic Neoplasms 181 Carcinoma, Hepatocellular 170 Stomach Neoplasms 139 Multiple Myeloma 128 Ovarian Neoplasms 121 Melanoma 120 Colonic Neoplasms 112 Brain Neoplasms 111 Hematologic Neoplasms 108 Head and Neck Neoplasms 108 Urinary Bladder Neoplasms 105 Leukemia, Myeloid, Acute 102 Disease 101 Esophageal Neoplasms 100 Neoplasm Metastasis 89 Liver Neoplasms 89 Uterine Cervical Neoplasms 88 Rectal Neoplasms 87 Lymphoma 85 Precursor Cell Lymphoblastic Leukemia-Lymphoma 84 Endometrial Neoplasms 76 Carcinoma, Renal Cell 72 Leukemia 64 Recurrence 63

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hormone Receptor Positive Breast Cancer × 1 year × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡